The efficacy of noninvasive oxygenation strategies (NIOS) in treating COVID-19 disease is unknown. We conducted a prospective observational study to assess the rate of NIOS failure in subjects treated in the ICU for hypoxemic respiratory failure due to COVID-19.
METHODS:
Patients receiving first-line treatment NIOS for hypoxemic respiratory failure due to COVID-19 in the ICU of a university hospital were included in this study; laboratory data were collected upon arrival, and 28-d outcome was recorded. After propensity score matching based on Simplified Acute Physiology (SAPS) II score, age, and at arrival, the NIOS failure rate in subjects with COVID-19 was compared to a previously published cohort who received NIOS during hypoxemic respiratory failure due to other causes.
RESULTS:
A total of 85 subjects received first-line treatment with NIOS. The most frequently used methods were helmet noninvasive ventilation and high-flow nasal cannula; of these, 52 subjects (61%) required endotracheal intubation. Independent factors associated with NIOS failure were SAPS II score (P = .009) and serum lactate dehydrogenase at enrollment (P = .02); the combination of SAPS II score ≥ 33 with serum lactate dehydrogenase ≥ 405 units/L at ICU admission had 91% specificity in predicting the need for endotracheal intubation. In the propensity-matched cohorts (54 pairs), subjects with COVID-19 showed higher risk of NIOS failure than those with other causes of hypoxemic respiratory failure (59% vs 35%, P = .02), with an adjusted hazard ratio of 2 (95% CI 1.1–3.6, P = .01).
CONCLUSIONS:
As compared to hypoxemic respiratory failure due to other etiologies, subjects with COVID-19 who were treated with NIOS in the ICU were burdened by a 2-fold higher risk of failure. Subjects with a SAPS II score ≥ 33 and serum lactate dehydrogenase ≥ 405 units/L represent the population with the greatest risk.
RochwergB, BrochardL, ElliottMW, HessD, HillNS, NavaS, et al. Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure. Eur Respir J, 2017; 50(2):1602426.
2.
DemouleA, GirouE, RichardJ-C, TailleS, BrochardL. Benefits and risks of success or failure of noninvasive ventilation. Intensive Care Med, 2006; 32(11):1756–1765.
3.
SivaloganathanAA, Nasim-MohiM, BrownMM, AbdulN, JacksonA, FletcherSV, et al. Noninvasive ventilation for COVID-19-associated acute hypoxaemic respiratory failure: experience from a single centre. Br J Anaesth, 2020; 125(4):e368–e371.
4.
GrasselliG, ZangrilloA, ZanellaA, AntonelliM, CabriniL, CastelliA, et al. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy. JAMA, 2020; 323(16):1574.
5.
FratJ-P, ThilleAW, MercatA, GiraultC, RagotS, PerbetS, et al. High-flow oxygen through nasal cannula in acute hypoxemic respiratory failure. N Engl J Med, 2015; 372(23):2185–2196.
6.
FerreyroBL, AngrimanF, MunshiL, Del SorboL, FergusonND, RochwergB, et al. Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis. JAMA, 2020; 324(1):57–67.
7.
LevineS, NguyenT, TaylorN, FrisciaME, BudakMT, RothenbergP, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Eng J Med, 2008; 358:331–341.
8.
SassoonCSH, ZhuE, CaiozzoVJ. Assist-control mechanical ventilation attenuates ventilator-induced diaphragmatic dysfunction. Am J Respir Crit Care Med, 2004; 170(6):626–632.
NeumannP, WriggeH, ZinserlingJ, HinzJ, MaripuuE, AnderssonLG, et al. Spontaneous breathing affects the spatial ventilation and perfusion distribution during mechanical ventilatory support. Crit Care Med, 2005; 33:1090–1095.
11.
MariniJJ. Spontaneously regulated vs. controlled ventilation of acute lung injury/acute respiratory distress syndrome. Curr Opin Crit Care, 2011; 17(1):24–29.
12.
YoshidaT, UchiyamaA, MatsuuraN, MashimoT, FujinoY. The comparison of spontaneous breathing and muscle paralysis in two different severities of experimental lung injury. Crit Care Med, 2013; 41(2):536–545.
13.
GriecoDL, MengaLS, EleuteriD, AntonelliM. Patient self-inflicted lung injury: implications for acute hypoxemic respiratory failure and ARDS patients on non-invasive support. Minerva Anestesiol, 2019; 85(9).
14.
YoshidaT, TorsaniV, GomesS, De SantisRR, BeraldoMA, CostaEV, et al. Spontaneous effort causes occult pendelluft during mechanical ventilation. Am J Respir Crit Care Med, 2013; 188(12):1420–1427.
15.
KalletRH, AlonsoJA, LuceJM, MatthayMA. Exacerbation of acute pulmonary edema during assisted mechanical ventilation using a low-tidal volume, lung-protective ventilator strategy. Chest, 1999; 116(6):1826–1832.
16.
GoligherEC, BrochardLJ, ReidWD, FanE, SaarelaO, SlutskyAS, et al. Diaphragmatic myotrauma: a mediator of prolonged ventilation and poor patient outcomes in acute respiratory failure. Lancet Respir Med, 2019; 7(1):90–98.
17.
GoligherEC, DresM, PatelBK, SahetyaSK, BeitlerJR, TeliasI, et al. Lung and diaphragm-protective ventilation. Am J Respir Crit Care Med, 2020; 202(7):950–961.
18.
DemouleA, ChevretS, CarlucciA, KouatchetA, JaberS, MezianiF, et al. Changing use of noninvasive ventilation in critically ill patients: trends over 15 years in francophone countries. Intensive Care Med, 2016; 42(1):82–92.
19.
BellaniG, LaffeyJG, PhamT, MadottoF, FanE, BrochardL, et al. Noninvasive ventilation of patients with acute respiratory distress syndrome: insights from the LUNG SAFE study. Am J Respir Crit Care Med, 2017; 195(1):67–77.
20.
AntonelliM, ContiG, MoroML, EsquinasA, Gonzalez-DiazG, ConfalonieriM, et al. Predictors of failure of noninvasive positive pressure ventilation in patients with acute hypoxemic respiratory failure: a multi-center study. Intensive Care Med, 2001; 27(11):1718–1728.
21.
OzyilmazE, UgurluAO, NavaS. Timing of noninvasive ventilation failure: causes, risk factors, and potential remedies. BMC Pulm Med, 2014; 14(1).
22.
AlraddadiBM, QushmaqI, Al-HameedFM, MandourahY, AlmekhlafiGA, JoseJ, et al. Noninvasive ventilation in critically ill patients with the middle east respiratory syndrome. Influenza Other Respi Viruses, 2019; 13(4):382–390.
23.
ArabiYM, ArifiAA, BalkhyHH, NajmH, AldawoodAS, GhabashiA, et al. Clinical course and outcomes of critically ill patients with Middle East respiratory syndrome coronavirus infection. Ann Intern Med, 2014; 160(6):389–397.
24.
Belenguer-MuncharazA, Reig-ValeroR, Altaba-TenaS, Casero-RoigP, Ferrándiz-SellésA. Noninvasive mechanical ventilation in severe pneumonia due to H1N1 virus. Med Intensiva, 2011; 35(8):470–477.
25.
EstenssoroE, RíosFG, ApezteguíaC, ReinaR, NeiraJ, CerasoDH, et al. Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation. Am J Respir Crit Care Med, 2010; 182(1):41–48.
26.
MasclansJR, PérezM, AlmirallJ, LorenteL, MarquésA, SociasL, et al. Early non-invasive ventilation treatment for severe influenza pneumonia. Clin Microbiol Infect, 2013; 19(3):249–256.
AlhazzaniW, MøllerMH, ArabiYM, LoebM, GongMN, FanE, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with coronavirus disease 2019 (COVID-19). Intensive Care Med, 2020; 46(5):854–887.
29.
VestboJ, HurdSS, AgustíAG, JonesPW, VogelmeierC, AnzuetoA, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med, 2013; 187(4):347–365.
30.
AntonelliM, ContiG, EsquinasA, MontiniL, MaggioreSM, BelloG, et al. A multiple-center survey on the use in clinical practice of noninvasive ventilation as a first-line intervention for acute respiratory distress syndrome. Crit Care Med, 2007; 35:18–25.
31.
WangK, ZhaoW, LiJ, ShuW, DuanJ. The experience of high-flow nasal cannula in hospitalized patients with 2019 novel coronavirus-infected pneumonia in two hospitals of Chongqing. Ann Intensive Care, 2020; 10(1):37.
32.
ZucmanN, MullaertJ, RouxD, RocaO, RicardJ-D. Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure. Intensive Care Med, 2020; 46(10):1924–1926.
33.
CarrilloA, Gonzalez-DiazG, FerrerM, Martinez-QuintanaME, Lopez-MartinezA, LlamasN, et al. Non-invasive ventilation in community-acquired pneumonia and severe acute respiratory failure. Intensive Care Med, 2012; 38(3):458–466.
34.
BrochardL, SlutskyA, PesentiA. Mechanical ventilation to minimize progression of lung injury in acute respiratory failure. Am J Respir Crit Care Med, 2017; 195(4):438–442.
35.
DuanJ, HanX, BaiL, ZhouL, HuangS. Assessment of heart rate, acidosis, consciousness, oxygenation, and respiratory rate to predict noninvasive ventilation failure in hypoxemic patients. Intensive Care Med, 2017; 43(2):192–199.
36.
LiuX, LiuX, XuY, XuZ, HuangY, ChenS, et al. Ventilatory ratio in hypercapnic mechanically ventilated patients with covid-19-associated acute respiratory distress syndrome. Am J Respir Crit Care Med, 2020; 201(10):1297–1299.
37.
ZiehrDR, AlladinaJ, PetriCR, MaleyJH, MoskowitzA, MedoffBD, et al. Respiratory pathophysiology of mechanically ventilated patients with COVID-19: a cohort study. Am J Respir Crit Care Med, 2020; 201(12):1560–1564.
38.
GriecoDL, BongiovanniF, ChenL, MengaLS, CutuliSL, PintaudiG, et al. Respiratory physiology of COVID-19-induced respiratory failure compared to ARDS of other etiologies. Crit Care, 2020; 24(1):529.
39.
DrentM, CobbenNAM, HendersonRF, WoutersEFM, van Dieijen-VisserM. Usefulness of lactate dehydrogenase and its isoenzymes as indicators of lung damage or inflammation. Eur Respir J, 1996; 9(8):1736–1742.
40.
MoraisCCA, KoyamaY, YoshidaT, PlensGM, GomesS, LimaCAS, et al. High positive end-expiratory pressure renders spontaneous effort noninjurious. Am J Respir Crit Care Med, 2018; 197(10):1285–1296.
41.
GriecoDL, MengaLS, RaggiV, BongiovanniF, AnzellottiGM, TanzarellaES, et al. Physiological comparison of high-flow nasal cannula and helmet noninvasive ventilation in acute hypoxemic respiratory failure. Am J Respir Crit Care Med, 2020; 201(3):303–312.
42.
YoshidaT, GriecoDL, BrochardL, FujinoY. Patient self-inflicted lung injury and positive end-expiratory pressure for safe spontaneous breathing. Curr Opin Crit Care, 2020; 26(1):59–65.
43.
Hernandez-RomieuAC, AdelmanMW, HocksteinMA, RobichauxCJ, EdwardsJA, FazioJC, et al. Timing of intubation and mortality among critically ill coronavirus disease 2019 patients: a single-center cohort study. Crit Care Med, 2020; 48(11):e1045–e1053.
44.
PatelBK, WolfeKS, PohlmanAS, HallJB, KressJP. Effect of noninvasive ventilation delivered by helmet vs face mask on the rate of endotracheal intubation in patients with acute respiratory distress syndrome: a randomized clinical trial. JAMA, 2016; 315(22):2435–2441.
